Griffith University, School of Medicine

Southport, Queensland 4222

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Relapsing-Remitting, Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis

Studies at this site

• Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis — Stopped early
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One — Completed